To systematically evaluate the efficacy and safety of Ningxinbao Capsules in treatment of arrhythmia by Meta-analysis. Randomized controlled trial(RCT) or quasi-randomized control trial(Quasi-RCT) on Ningxinbao Capsules treating arrhythmia were obtained by computer-based retrieval in CNKI, Wanfang, VIP, SinoMed, PubMed, Web of Science, Cochrane Library and EMbase as well as manual retrieval, with time limit from database establishment to April 7, 2020. According to the inclusion and exclusion criteria of trials, all RCTs were screened and evaluated. Then the effective data were collected and RevMan 5.3 Meta-analysis software was used for analysis. Thirteen trials were included, involving 1 379 patients in total. Ningxinbao Capsules combined with anti-arrhythmia Western medicine were adopted as the intervention, and the patients in control group were treated with the anti-arrhythmia Western medicine alone. Meta-analysis results showed that as compared to control group, Ningxinbao Capsules combined with anti-arrhythmia Western medicine group was superior in clinical efficacy, dynamic electrocardiogram and average heart rate in patients with bradycardia, with indicated statistically significant differences. Ningxinbao Capsules had fewer adverse reactions and could relieve the toxic and side effects of anti-arrhythmia medicine possibly. The study showed that Ningxinbao Capsules played a role in treatment of arrhythmia and was relatively safe. However, due to the limited quality of the included studies, high-quality clinical trials are needed to verify the conclusions.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.19540/j.cnki.cjcmm.20200702.502 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Bidirectional regulatory effects of Cordyceps on arrhythmia: Clinical evaluations and network pharmacology.
Front Pharmacol
August 2022
Key Laboratory of Biotechnology Drug (Shandong Academy of Medical Sciences), Biomedical Sciences College and Shandong Medicinal Biotechnology Centre, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
Cordyceps is a precious Chinese herbal medicine with rich bio-active ingredients and is used for regulating arrhythmia alongside routine treatments. However, the efficacy and potential mechanisms of Cordyceps on patients with arrhythmia remain unclear. Randomized controlled trials of bradycardia treatment with Cordyceps were retrieved from diverse databases and available data.
View Article and Find Full Text PDF[Fingerprint establishment and multi-indicator quantitative analysis of fermented powder and products].
Se Pu
September 2021
State Key Laboratory for Quality Research of Chinese Medicine, University of Macau, Macao 999078, China.
Currently, guanosine, adenosine, and uridine contents are specified as the quality criteria for related products in the quality standards for fermented powder preparations included in the 2020 edition of Chinese Pharmacopoeia. However, there are many other nucleosides in fermented powder, whose effect on the quality control has not yet been discussed. In this study, an ultra-performance liquid chromatography-ultraviolet detection (UPLC-UV) method was used for the quantitative analysis of 9 nucleosides (uracil, cytidine, guanidine, uridine, adenine, inosine, guanosine, thymidine, and adenosine) in 19 batches of fermented powder samples and products, and the corresponding fingerprints were established.
View Article and Find Full Text PDF[Systematic review and Meta-analysis of efficacy and safety of Ningxinbao Capsules in treatment of arrhythmia].
Zhongguo Zhong Yao Za Zhi
March 2021
Dongzhimen Hospital, Beijing University of Chinese Medicine Beijing 100700,China.
To systematically evaluate the efficacy and safety of Ningxinbao Capsules in treatment of arrhythmia by Meta-analysis. Randomized controlled trial(RCT) or quasi-randomized control trial(Quasi-RCT) on Ningxinbao Capsules treating arrhythmia were obtained by computer-based retrieval in CNKI, Wanfang, VIP, SinoMed, PubMed, Web of Science, Cochrane Library and EMbase as well as manual retrieval, with time limit from database establishment to April 7, 2020. According to the inclusion and exclusion criteria of trials, all RCTs were screened and evaluated.
View Article and Find Full Text PDF[Network Meta-analysis of randomized controlled trials of Chinese patent medicine for bradyarrhythmia].
Zhongguo Zhong Yao Za Zhi
March 2020
Evidence Based Medicine Center, Tianjin University of Traditional Chinese Medicine Tianjin 300193, China.
To assess the clinical efficacy of Chinese patent medicine for bradyarrhythmia(BA) by using network Meta-analysis method. Relevant randomized controlled trials(RCTs) of Chinese patent medicine for BA were retrieved from China National Knowledge Infrastructure(CNKI), WanFang Database, VIP database, SinoMed, PubMed and Cochrane Library. The retrieval time ranged from the commencement of each database to February 2019.
View Article and Find Full Text PDFGC-MS Profiling of Volatile Components in Different Fermentation Products of Cordyceps Sinensis Mycelia.
Molecules
October 2017
School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, China.
The fermentation products of () mycelia are sustainable substitutes for natural . However, the volatile compositions of the commercial products are still unclear. In this paper, we have developed a simultaneous distillation-extraction (SDE) and gas chromatography-mass spectrometry (GC-MS) method for the profiling of volatile components in five fermentation products.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!